Related Experiment Video
Updated: May 15, 2026
05:47
Animal Models of Depression - Chronic Despair Model (CDM)
Published on: September 23, 2021
The DEX/CRH test for major depression: a potentially useful diagnostic test
Mohammadreza Mokhtari1, Cynthia Arfken, Nash Boutros
1Department of Psychiatry and Behavioral Neurosciences, Wayne State University, 2751 East Jefferson Avenue, Suite 437, Detroit, MI 48207, USA. mmokhtari@harthosp.org
Psychiatry Research
|January 8, 2013
Summary
The dexamethasone/corticotropin-releasing hormone (DEX/CRH) test shows promise for diagnosing major depressive disorder (MDD). However, further research is needed to validate its clinical utility through advanced study stages.
Area of Science:
- Neuroscience
- Psychiatry
- Biomarker Research
Background:
- Major depressive disorder (MDD) lacks definitive diagnostic biomarkers.
- The dexamethasone/corticotropin-releasing hormone (DEX/CRH) test is a potential neuroendocrine marker for MDD.
Purpose of the Study:
- To evaluate the developmental stage of the DEX/CRH test as a diagnostic tool for MDD.
- To assess the progress of the DEX/CRH test using a four-step model for diagnostic test development.
Main Methods:
- Literature review of 15 studies comparing DEX/CRH test results in MDD patients and healthy controls.
- Meta-analysis of 8 eligible studies to estimate effect size, heterogeneity, and confidence intervals.
- Categorization of studies according to a four-step development framework.
Main Results:
- Eleven studies indicated significantly higher cortisol levels in MDD patients post-DEX/CRH test (Step 1).
- Meta-analysis yielded an effect size of 1.34 (95% CI: 0.70-1.97).
- Most studies were Step 1; no Step 4 (multicenter trials) were identified.
Conclusions:
- The DEX/CRH test shows potential but requires further rigorous study.
- Additional Step 3 and Step 4 research is essential for clinical validation.
- Current evidence is insufficient for widespread clinical adoption of the DEX/CRH test for MDD diagnosis.
Related Concept Videos
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:27Diagnostic and Statistical Manual of Mental Disorders (DSM)
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
01:27Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
01:05Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
01:03Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Calcium Ion Concentration Mechanism
If over time, all...
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.